ImmunoACT has portfolio of Chimeric Antigen Receptor T cells (CAR-T cells) therapy assets under various development stages for the treatment of multiple auto immune diseases and oncology indications.
The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab .
India's 1st homegrown mRNA Covid vax may have low market penetration: Report indianewengland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianewengland.com Daily Mail and Mail on Sunday newspapers.